Diagnostic Utility of Ischemic Modified Albumin in Young Adult Patients with Acute Coronary Syndrome

AKYOL, K. Can; KEŞAPLI, Mustafa; Bayar, Nermin; ÇELİK, Ahmet; GÜVEN, Ramazan; YAŞAR ELLİDAĞ, Hamit; GÜNGÖR, FARUK; AYKAL, Güzin

Diagnostic Utility of Ischemic Modified Albumin in Young Adult Patients with Acute Coronary Syndrome

Ramazan GÜVEN, (Bitlis Devlet Hastanesi, Acil Tıp Kliniği, Bitlis, Türkiye)

K. Can AKYOL, (Antalya Eğitim ve Araştırma Hastanesi, Acil Tıp Anabilim Dalı, Antalya, Türkiye)

Nermin BAYAR, (Antalya Eğitim ve Araştırma Hastanesi, Kardiyoloji Kliniği, Antalya, Türkiye)

Güzin AYKAL, (Sağlık Bakanlığı, Antalya Eğitim ve Araştırma Hastanesi, Biyokimya Kliniği, Antalya, Türkiye)

Faruk GÜNGÖR, (Antalya Eğitim ve Araştırma Hastanesi, Acil Tıp Anabilim Dalı, Antalya, Türkiye)

Mustafa KEŞAPLI, (Antalya Eğitim ve Araştırma Hastanesi, Acil Tıp Anabilim Dalı, Antalya, Türkiye)

Hamit YAŞAR ELLİDAĞ, (Sağlık Bakanlığı, Antalya Eğitim ve Araştırma Hastanesi, Biyokimya Kliniği, Antalya, Türkiye)

Ahmet ÇELİK (Antalya Eğitim ve Araştırma Hastanesi, Acil Tıp Anabilim Dalı, Antalya, Türkiye)

Journal of Clinical and Analytical Medicine

1 0

Yıl: 2016 Cilt: 7 Sayı: 5 Sayfa Aralığı: 690 - 694 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Diagnostic Utility of Ischemic Modified Albumin in Young Adult Patients with Acute Coronary Syndrome

Öz:

Amaç: Bu çalışmayla AKS tanısında IMA'nın yalnız başına ve TnI ile birlikte kullanıldığındaki pozitif ve negatif olabilirlik oranını araştırdık. Çalışma 3 gruba ayrılarak incelendi. Birinci grup normal koroner arterlere sahip vakalardan (n=40), ikinci grup ST segment yükselmesi olan miyokardiyal enfarktüs (STEMI) hastalarından (n=49) ve üçüncü grup ST segment yükselmesi olmayan miyokardiyal enfarktüs - Kararsız Angina (NSTEMI-KA) hastalarından (n=47) oluşturuldu. IMA'nın, AKS hastalarını kontrol grubundan ayırt etmede TnI ve diğer kardiyak markırlardan üstünlüğünün olmadığı görüldü. Ancak AKS hastalarında TnI ve IMA kombinasyonunun, TnI'nin yalnız başına kullanımından daha yüksek bir oranda dışlayıcılığı olduğunu saptadık

Anahtar Kelime:

Konular: Genel ve Dahili Tıp

Genç Erişkin Akut Koroner Sendrom Hastalarında Iskemik Modifiye Albumin'in Tanısal Yararlığı

Öz:

Aim: In this study, we investigated the diagnostic value of IMA in the positive and negative predictive value of ACS, alone and in combination with TnI. The study population was divided into 3 groups. The first group included those patients with normal coronary arteries (n=40), the second group included the ACS patients with ST segment elevation myocardial infarction (STEMI) (n=49), and the third group included the ACS patients with Non ST-segment elevation myocardial infarction-Unstable Angina (NSTEMI-UA) (n=47). Although its use for diagnostic purposes did not provide an additional benefit for ACS patients, we found that the combination of TnI and IMA could better rule out ACS compared to TnI alone

Anahtar Kelime:

Konular: Genel ve Dahili Tıp

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial. Third universal definition of myocardial infarction. Eur Heart J 2012;33:2551-67.
2. Bar-Or D, Lau E, Winkler JV. Novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia–a preliminary report. J Emerg Med 2000;19:311-5.
3. Chawla R, Goyal N. Ischemia Modified Albumin: A Novel Marker For Acute Coronary Syndrome. Indian Journal of Clinical Biochemistry 2006;21(1):77-82.
4. Sinha MK, Gaze DC, Tippins JR, Collinson PO, Kaski JC. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 2003;107:2403-5.
5. Panteghini M. Role of importance of biochemical markers in clinical cardiology. Eur Heart J 2004;25:1187–96.
6. Lindahl B. Detection of myocardial damage: are the troponins the ultimate solution? Scand Cardiovasc J 2001;35:229–32.
7. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal 2011;32:2999– 3054.
8. Worster A, Devereaux PJ, Heels-Ansdell D, Guyatt GH, Opie J, Mookadam F, et al. Capability of ischemia-modified albumin to predictserious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ 2005;172:1685-90.
9. Roy D, Quiles J, Aldama G, Sinha M, Avanzas P, Arroyo-Espliguero R et al. Ischemia Modified Albumin for the assessment of patients presenting to the emer-gency department with acute chest pain but normal or non-diagnostic 12 derivations and negative cardiac troponin T. Int J Cardiol 2004;97(2):297-301.
10. Gurumurthy P, Borra SK, Yeruva RKR, Victor D, Babu S, Cherian KM. Estimation of Ischemia Modified Albumin (IMA) Levels in Patients with Acute Coronary Syndrome. Ind J Clin Biochem 2014;29(3):367–71.
11. Reddy CB, Cyriac C, Desle HB. Role of “Ischemia Modified Albumin” (IMA) in acute coronary syndromes. Indian Heart Journal 2014;66:656-62.
12. Çevik E, Yılmaz BK , Acar YA, Haklıgör A, Çınar O. Bazı erken kardiyak belirteçlerin (Miyoglobin, IMA ve Copeptin) tanısal performansının STEMI hastalarında değerlendirilmesi. Türk Acil Tıp Derg 2013;13(3):127-32.
13. Søren H, Risom K, Jan R. Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome. Am J Emerg Med 2010;28:170-6.
14. Christenson RH, Duh SH, Sanhai WR, Wu AH, Holtman V, Painter P, et al. Characteristics of an albümin cobalt binding test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 2001;47:464-70.
15. Özdem S, Çete Y, Dönmez L, Başarıcı İ, Bakır A, Akbaş H, Gültekin M. Sağlıklı Yetişkinlerde ve Akut Koroner Sendromlu Hastalarda Serum lskemi Modifiye Albumin (IMA) Düzeyleri. Türk Acil Tıp Derg 2005;5(4):169-74.
16. Takhshid MA, Kojuri J, Tabei SMB, Tavasouli AR, Heidary S, Tabandeh M. Early Diagnosis of Acute Coronary Syndrome with Sensitive Troponin I and Ischemia Modified Albumin. Iranian Cardiovascular Research Journal 2010;4(4):144-51.
17. Lee YW, Kim HJ, Cho YH, Shin HB, Choi TY, Lee YK. Application of albuminadjusted ischemia modified albümin index as an early screening marker for acute coronary syndrome. Clin Chim Acta. 2007; 384:24-7.
18. Peacock F, Morris DL, Anwaruddin S, Christenson RH, Collinson PO, Goodacre SW, et al. Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J. 2006; 152:253-62.

APA	GÜVEN R, AKYOL K, Bayar N, AYKAL G, GÜNGÖR F, KEŞAPLI M, YAŞAR ELLİDAĞ H, ÇELİK A (2016). Diagnostic Utility of Ischemic Modified Albumin in Young Adult Patients with Acute Coronary Syndrome. , 690 - 694.
Chicago	GÜVEN Ramazan,AKYOL K. Can,Bayar Nermin,AYKAL Güzin,GÜNGÖR FARUK,KEŞAPLI Mustafa,YAŞAR ELLİDAĞ Hamit,ÇELİK Ahmet Diagnostic Utility of Ischemic Modified Albumin in Young Adult Patients with Acute Coronary Syndrome. (2016): 690 - 694.
MLA	GÜVEN Ramazan,AKYOL K. Can,Bayar Nermin,AYKAL Güzin,GÜNGÖR FARUK,KEŞAPLI Mustafa,YAŞAR ELLİDAĞ Hamit,ÇELİK Ahmet Diagnostic Utility of Ischemic Modified Albumin in Young Adult Patients with Acute Coronary Syndrome. , 2016, ss.690 - 694.
AMA	GÜVEN R,AKYOL K,Bayar N,AYKAL G,GÜNGÖR F,KEŞAPLI M,YAŞAR ELLİDAĞ H,ÇELİK A Diagnostic Utility of Ischemic Modified Albumin in Young Adult Patients with Acute Coronary Syndrome. . 2016; 690 - 694.
Vancouver	GÜVEN R,AKYOL K,Bayar N,AYKAL G,GÜNGÖR F,KEŞAPLI M,YAŞAR ELLİDAĞ H,ÇELİK A Diagnostic Utility of Ischemic Modified Albumin in Young Adult Patients with Acute Coronary Syndrome. . 2016; 690 - 694.
IEEE	GÜVEN R,AKYOL K,Bayar N,AYKAL G,GÜNGÖR F,KEŞAPLI M,YAŞAR ELLİDAĞ H,ÇELİK A "Diagnostic Utility of Ischemic Modified Albumin in Young Adult Patients with Acute Coronary Syndrome." , ss.690 - 694, 2016.
ISNAD	GÜVEN, Ramazan vd. "Diagnostic Utility of Ischemic Modified Albumin in Young Adult Patients with Acute Coronary Syndrome". (2016), 690-694.

APA	GÜVEN R, AKYOL K, Bayar N, AYKAL G, GÜNGÖR F, KEŞAPLI M, YAŞAR ELLİDAĞ H, ÇELİK A (2016). Diagnostic Utility of Ischemic Modified Albumin in Young Adult Patients with Acute Coronary Syndrome. Journal of Clinical and Analytical Medicine, 7(5), 690 - 694.
Chicago	GÜVEN Ramazan,AKYOL K. Can,Bayar Nermin,AYKAL Güzin,GÜNGÖR FARUK,KEŞAPLI Mustafa,YAŞAR ELLİDAĞ Hamit,ÇELİK Ahmet Diagnostic Utility of Ischemic Modified Albumin in Young Adult Patients with Acute Coronary Syndrome. Journal of Clinical and Analytical Medicine 7, no.5 (2016): 690 - 694.
MLA	GÜVEN Ramazan,AKYOL K. Can,Bayar Nermin,AYKAL Güzin,GÜNGÖR FARUK,KEŞAPLI Mustafa,YAŞAR ELLİDAĞ Hamit,ÇELİK Ahmet Diagnostic Utility of Ischemic Modified Albumin in Young Adult Patients with Acute Coronary Syndrome. Journal of Clinical and Analytical Medicine, vol.7, no.5, 2016, ss.690 - 694.
AMA	GÜVEN R,AKYOL K,Bayar N,AYKAL G,GÜNGÖR F,KEŞAPLI M,YAŞAR ELLİDAĞ H,ÇELİK A Diagnostic Utility of Ischemic Modified Albumin in Young Adult Patients with Acute Coronary Syndrome. Journal of Clinical and Analytical Medicine. 2016; 7(5): 690 - 694.
Vancouver	GÜVEN R,AKYOL K,Bayar N,AYKAL G,GÜNGÖR F,KEŞAPLI M,YAŞAR ELLİDAĞ H,ÇELİK A Diagnostic Utility of Ischemic Modified Albumin in Young Adult Patients with Acute Coronary Syndrome. Journal of Clinical and Analytical Medicine. 2016; 7(5): 690 - 694.
IEEE	GÜVEN R,AKYOL K,Bayar N,AYKAL G,GÜNGÖR F,KEŞAPLI M,YAŞAR ELLİDAĞ H,ÇELİK A "Diagnostic Utility of Ischemic Modified Albumin in Young Adult Patients with Acute Coronary Syndrome." Journal of Clinical and Analytical Medicine, 7, ss.690 - 694, 2016.
ISNAD	GÜVEN, Ramazan vd. "Diagnostic Utility of Ischemic Modified Albumin in Young Adult Patients with Acute Coronary Syndrome". Journal of Clinical and Analytical Medicine 7/5 (2016), 690-694.